Lido Advisors, LLC Bristol Myers Squibb CO Transaction History

Lido Advisors, LLC

  • $20.3 Billion
  • Q3 2024

A detailed history of Lido Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lido Advisors, LLC holds 134,028 shares of BMY stock, worth $7.61 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
134,028
Previous 128,765 4.09%
Holding current value
$7.61 Million
Previous $5.35 Million 29.7%
% of portfolio
0.03%
Previous 0.03%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $208,730 - $272,360
5,263 Added 4.09%
134,028 $6.94 Million
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $1.62 Million - $2.14 Million
-40,359 Reduced 23.86%
128,765 $5.35 Million
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $1.78 Million - $2.02 Million
37,046 Added 28.05%
169,124 $9.17 Million
Q4 2023

Feb 14, 2024
BUY
$48.48 - $57.85 $1 Million - $1.2 Million
20,687 Added 18.57%
132,078 $6.78 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $3.88 Million - $4.34 Million
-67,009 Reduced 37.56%
111,391 $6.47 Million
Q2 2023

Aug 09, 2023
BUY
$63.71 - $70.74 $583,583 - $647,978
9,160 Added 5.41%
178,400 $11.4 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $5.93 Million - $6.73 Million
90,239 Added 114.23%
169,240 $11.7 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $372,257 - $440,805
5,436 Added 7.39%
79,001 $5.68 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $167 - $98,739
-1,285 Reduced 1.72%
73,565 $5.23 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $586,769 - $646,238
8,080 Added 12.1%
74,850 $5.76 Million
Q1 2022

May 17, 2022
BUY
$61.48 - $73.72 $1.02 Million - $1.22 Million
16,545 Added 32.94%
66,770 $4.88 Million
Q4 2021

Feb 15, 2022
BUY
$53.63 - $62.52 $238,760 - $278,339
4,452 Added 9.73%
50,225 $3.13 Million
Q3 2021

Feb 15, 2022
BUY
$59.17 - $69.31 $65,264 - $76,448
1,103 Added 2.47%
45,773 $2.71 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $572,883 - $671,059
9,682 Added 27.67%
44,670 $2.67 Million
Q2 2021

Aug 12, 2021
BUY
$61.91 - $67.42 $144,312 - $157,156
2,331 Added 7.14%
34,988 $2.34 Million
Q1 2021

May 13, 2021
SELL
$59.34 - $66.74 $256,764 - $288,783
-4,327 Reduced 11.7%
32,657 $2.08 Million
Q4 2020

Feb 08, 2021
BUY
$57.74 - $65.43 $365,898 - $414,629
6,337 Added 20.68%
36,984 $2.31 Million
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $117,961 - $130,716
-2,054 Reduced 6.28%
30,647 $1.85 Million
Q2 2020

Aug 12, 2020
BUY
$54.82 - $64.09 $179,316 - $209,638
3,271 Added 11.11%
32,701 $1.92 Million
Q1 2020

May 13, 2020
SELL
$46.4 - $67.43 $406,185 - $590,282
-8,754 Reduced 22.93%
29,430 $1.64 Million
Q4 2019

Feb 07, 2020
BUY
$49.21 - $64.19 $593,866 - $774,644
12,068 Added 46.21%
38,184 $2.45 Million
Q3 2019

Nov 12, 2019
BUY
$42.77 - $50.71 $351,697 - $416,988
8,223 Added 45.96%
26,116 $1.32 Million
Q2 2019

Aug 14, 2019
BUY
$44.62 - $49.34 $160,364 - $177,327
3,594 Added 25.13%
17,893 $811,000
Q1 2019

May 10, 2019
SELL
$45.12 - $53.8 $39,570 - $47,182
-877 Reduced 5.78%
14,299 $682,000
Q4 2018

Feb 14, 2019
BUY
$48.76 - $63.23 $99,080 - $128,483
2,032 Added 15.46%
15,176 $788,000
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $507,692 - $572,637
9,199 Added 233.18%
13,144 $815,000
Q2 2018

Aug 14, 2018
SELL
$50.53 - $62.98 $3,840 - $4,786
-76 Reduced 1.89%
3,945 $218,000
Q1 2018

May 10, 2018
SELL
$59.92 - $68.98 $6,291 - $7,242
-105 Reduced 2.54%
4,021 $254,000
Q4 2017

Feb 15, 2018
SELL
$59.94 - $65.35 $12,227 - $13,331
-204 Reduced 4.71%
4,126 $252,000
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $239,145 - $275,994
4,330 New
4,330 $267,000
Q3 2016

Sep 21, 2017
SELL
N/A
-6,729 Closed
0 $0
Q2 2016

Sep 18, 2017
BUY
N/A
6,729
6,729 $495,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email